Literature DB >> 34028789

A case of treatment-resistant pityriasis rubra pilaris responsive to secukinumab.

Kate Simpson1, Con Dolianitis2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34028789     DOI: 10.1111/ajd.13614

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


× No keyword cloud information.
  1 in total

1.  Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID-19 vaccination.

Authors:  Ya-Ting Liu; Shang-Shang Wang
Journal:  Skin Health Dis       Date:  2022-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.